A solution was proposed by Elgogary et al
GLP-1 Microdosing vs
Ramracheya R, Ward C, Shigeto M et al (2010) Membrane potential-dependent inactivation of voltage-gated ion channels in alpha-cells inhibits glucagon secretion from human islets
Cells were suspended in MEM, centrifuged for 10 min at 100 g then cultured in medium (MEM [Gibco], 10% FBS [Gibco], 4 mM L-glutamin [Sigma] + 2.5 g/ml amphotericin B [Gibco], 0.04 mg/ml Gentamicin [Gentamicin Sandoz 80 mg/ml]) for 14 days at 37 C, 5% CO 2
Author correction: Glp-1-based therapies for diabetes, obesity and beyond
While emerging research is promising, we do not yet have sufficient long-term data to fully understand how these medications impact egg quality, embryo development, or pregnancy outcomes